Domů › Rakovina prsu › Michigan › Ann Arbor
Klinické studie Rakovina prsu v Ann Arbor, MI
26 studií pro Rakovina prsu hledá účastníky v lokalitách v Ann Arbor a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · Vzdálenost 7 mi
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Vzdálenost 7 mi
- a dalších 4
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Probíhá náborFáze 1/2
- University of Michigan, Ann Arbor
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Probíhá náborFáze 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Probíhá náborFáze 3
- Clinical Trial Site, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Probíhá náborFáze 1
- University of Michigan, Ann Arbor
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Probíhá náborFáze 3
- University of Michigan, Ann Arbor
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
Probíhá náborObservační studie
- Trinity Health, Ann Arbor
Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial
Probíhá náborFáze 3
- Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Probíhá náborFáze 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · Vzdálenost 7 mi
- a dalších 6
Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction
Probíhá náborFáze 2Vítáni zdraví dobrovolníci
- University of Michigan Rogel Cancer Center, Ann Arbor
E-Mindfulness Approaches for Living After Breast Cancer
Probíhá náborFáze 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Probíhá náborFáze 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
Probíhá náborFáze 1
- University of Michigan, Ann Arbor
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
Probíhá náborFáze 4
- University of Michigan Rogel Cancer Center, Ann Arbor
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
Probíhá náborFáze 2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Probíhá náborFáze 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Vzdálenost 7 mi
- a dalších 5
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Probíhá náborFáze 1/2
- Trinity Health, Ypsilanti · Vzdálenost 7 mi
CIPN Decision Aid for the Improvement of Chemotherapy Decision Making in Patients With Breast Cancer
Probíhá nábor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Probíhá náborObservační studie
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Probíhá nábor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Ann Arbor
The Cancer of the Pancreas Screening-5 CAPS5)Study
Probíhá náborFáze 3
- University of Michigan, Ann Arbor
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Probíhá náborFáze 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Vzdálenost 7 mi
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of Michigan, Ann Arbor
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
Probíhá náborFáze 1
- University of Michigan, Ann Arbor
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Probíhá náborObservační studie
- Trinity Health-Michigan, Ypsilanti · Vzdálenost 7 mi
Studie Rakovina prsu v jiných městech
- New York City, NY134 studií
- Houston, TX126 studií
- Boston, MA111 studií
- Nashville, TN80 studií
- Los Angeles, CA72 studií
- Edison, NJ68 studií
- St. Louis, MO64 studií
- Durham, NC63 studií
- Queens, NY63 studií
- Chicago, IL58 studií
- Philadelphia, PA56 studií
- Dallas, TX55 studií
Další studie v Ann Arbor
- Rakovina prostaty27 studií
- Nemalobuněčný plicní karcinom26 studií
- Rakovina (všechny typy)25 studií
- Kolorektální karcinom23 studií
- Rakovina plic23 studií
- Srdeční selhání22 studií
- Akutní myeloidní leukemie17 studií
- Kardiovaskulární onemocnění16 studií
- Rakovina slinivky břišní14 studií
- Melanom12 studií
- Rakovina ledvin (renální buněčný karcinom)12 studií
- Squamózní buněčný karcinom hlavy a krku12 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.